Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
Alastair Mills, Managing Director & Head of European Business Services at H.I.G. Capital, joins Criticaleye’s Senior Editor Jacob Ambrose Willson to share his perspective on what lies ahead...
Matthew Blagg, CEO for Criticaleye, joins Marketing and Communications Director Julia Brook for the first Inspiring Leaders podcast for 2026. They take a look at some of the lessons for leaders last year, and examin...
Dave Wilson, Chair of LBG Media (LADbible) and Knights plc, joins Criticaleye’s Senior Editor Jacob Ambrose Willson to explore how Boards and executive teams can successfully navigate today’s capital markets...
Displaying 1 to 3 of 404
 (002).png "Palo Alto Networks"){kind=logo}
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
